Accelerating Biologics Discovery & Development Through Transformative Technologies & Overcoming Strategic Challenges
A concise report featuring insights from the prominent thought leaders of Biologics 2024
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
.jpg)
Antibody & Protein Engineering
Q&A with Silvia Crescioli, Business Intelligence Creator, The Antibody Society
We catch up with Silvia Crescioli from The Antibody Society to unpack the latest trends and technologies fuelling progress in antibody therapeutic development.
Antibody / Protein Production & Purification
Fast-Track Formulation with Biologics Screening in a Snap
On-demand webinar presented by Ross Walton, Senior Application Scientist for Analytics at Unchained Labs
NextGen Therapeutics
Historic Islet Cell Transplant Offers Hope for a Permanent Cure for Type 1 Diabetes
A study led by Professor Deng Hongkui at Peking University successfully treated a type 1 diabetes patient by transplanting insulin-producing islet cells derived from the patient's reprogrammed stem cells.
NextGen Therapeutics
Lonza and Vertex Pen Long Term Supply Deal for CASGEVY
Lonza will provide scientific, regulatory and manufacturing capabilities to Vertex, as well as use of their global manufacturing network.
NextGen Therapeutics
Tackling Tumours from Within: Tumour Reprogramming Offers Hope in Cancer Immunotherapy
A novel gene therapy developed by Asgard Therapeutics and Lund University reprograms tumour cells into cancer-fighting immune cells.
Antibody & Protein Engineering
Absci to Collaborate with the Memorial Sloan Kettering Cancer Center to Develop Biologics using AI
The two organisations will work side by side on up to six programmes which will develop new cancer drug candidates using AI.
Peptide Chemistry
RSC 'Emerging Technologies' Award Goes to Solid Phase Peptide Synthesis Group
The novel peptide synthesis protocol allows the synthesis of multiple peptide fragments on a single bead.
Cell Therapy Development
Exploring Innovative Approaches Throughout the CGT Development Journey
A Concise Report Featuring Insights From The Prominent Thought Leaders Of Cell UK
Regulatory
FDA Fast Track ADC for Patients with Triple Negative Breast Cancer
The fast track designation means that the clinical development and regulatory milestones of the drug candidate are likely to progress much faster.
NextGen Therapeutics
GSK Buys CureVac's mRNA Vaccine Business Providing Welcome Cash Injection
CureVac will continue to build its R&D pipeline while allowing GSK to develop and commercialise a handful of its prophylactic mRNA vaccines.
Immuno-Oncology
Unlocking the Future of Immune Cancer Therapy
A concise report featuring insights from the prominent though leaders of Immuno 2024.
Bioanalysis
2002 Nobel Prize for Chemistry: Kurt Wüthrich, Using NMR to Determine the 3D Structure of Proteins
Kurt Wüthrich, joint winner of the 2002 Nobel Prize for Chemistry, contributed to the use of NMR to discover the 3D structure of proteins using sequential assignment and mathematical techniques.